by Christine Hansen for MDBizMedia

A delegation from Rhode Island listens to a presentation by UMB Health Sciences and Research Park Corporation President Jim Hughes. In the front row, from left to right: Rhode Island Speaker Gordon Fox; DBED Secretary Christian Johansson; Maryland Speaker of the House Michael Busch; and Rhode Island Governor Lincoln Chafee.
Rhode Island Governor Lincoln Chafee, Providence Mayor Angel Taveras, Rhode Island Senate President Teresa Paiva-Weed and Rhode Island Speaker of the House Gordon Fox, and other Rhode Island officials, visited the University of Maryland Baltimore’s BioPark on a fact-finding mission to develop a life sciences-centered urban economic development based on the UMB Biopark model.

Map of the UMB Biopark. The Biopark is located across the University of Maryland Medical Center. The link between education and economic development is critical and a key reason why Maryland has been able to move its life sciences industry forward.
The delegation arrived this morning and took a walking tour of the University of Maryland Medical Center, including the Nursing, Dental, Medical and Pharmacy schools. The delegation then met with Maryland officials, including DBED Secretary Christian Johansson, Speaker of the House Michael Busch, and Baltimore Mayor Stephanie Rawlings-Blake, for a working lunch session.
“Governor Chafee, Mayor Taveras, Senate President Paiva-Weed, House Speaker Fox and esteemed guests from Rhode Island, I want to thank you for calling on us to learn more about how Maryland has positioned itself as a leader in the life sciences,” Secretary Johansson said.
“The success of this park is due largely in part to the tremendous collaboration that we have had with academia and our research parks around the State.”
In the past five years, the UMB Biopark has built three research buildings totaling 475,000 square feet, has generated $180 million in capital investment and created 427 jobs to date. Baltimore City donated the 10 acres of land for the University, and the State of Maryland provided a $4 million Sunny Day loan to tenants for build-out costs for Building One of the Biopark. The Biopark received a $1 million no interest loan from TEDCO that was matched by the Park’s developer, Wexford Science & Technology, which supported the building of the BioInnovation Center.
University officials stressed the important link between educational institutions and economic development. In 2009 alone, employment in the biosciences was at 30,000, with an average annual salary of $80,000. From 2002 to 2007, University bioscience research grew from $878 million to $1.3 billion.
“Last year, we awarded more than $1 million in grants to assist in commercializing promising research, encouraging bio companies to collaborate with academic institutions and expand biotechnology resources. And we have continued to grow our very successful Biotech Tax Credit program, funded at $8 million again this year to help emerging bio companies leverage seed and early stage funding,” Secretary Johansson said.
To date, the Biotech Tax Credit program has enabled dozens of Maryland bio companies to raise more than $60 million from investors. Companies, like Gliknik, who received almost $3 million from 2007 to 2009, are located at the UMB Biopark. Gliknik was among the companies that Governor Chafee visited during his tour of the Biopark.










































